Aaron M. Wohlrab, Ph.D. - Publications
Affiliations: | 2007 | Chemistry | University of California, San Diego, La Jolla, CA |
Area:
identification of novel antibacterial agents that function via inhibition of bacterial cell wall (peptidoglycan) biosynthesis, synthesis and biological study of novel agents for use in cancer chemotherapyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Kim SJ, Singh M, Wohlrab A, Yu TY, Patti GJ, O'Connor RD, VanNieuwenhze M, Schaefer J. The isotridecanyl side chain of plusbacin-A3 is essential for the transglycosylase inhibition of peptidoglycan biosynthesis. Biochemistry. 52: 1973-9. PMID 23421534 DOI: 10.1021/Bi4000222 | 0.469 | |||
2008 | Lee SW, Mitchell DA, Markley AL, Hensler ME, Gonzalez D, Wohlrab A, Dorrestein PC, Nizet V, Dixon JE. Discovery of a widely distributed toxin biosynthetic gene cluster. Proceedings of the National Academy of Sciences of the United States of America. 105: 5879-84. PMID 18375757 DOI: 10.1073/Pnas.0801338105 | 0.313 | |||
2007 | Perelman LA, Schwartz MP, Wohlrab AM, Vannieuwenhze MS, Sailor MJ. A simplified biomolecule attachment strategy for biosensing using a porous Si oxide interferometer. Physica Status Solidi (a): Applied Research. 204: 1394-1398. PMID 18458749 DOI: 10.1002/Pssa.200674360 | 0.397 | |||
2007 | Wohlrab A, Lamer R, VanNieuwenhze MS. Total synthesis of plusbacin A3: a depsipeptide antibiotic active against vancomycin-resistant bacteria. Journal of the American Chemical Society. 129: 4175-7. PMID 17371023 DOI: 10.1021/Ja068455X | 0.473 | |||
Show low-probability matches. |